quinazolines has been researched along with Degenerative Disc Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuai, J; Zhang, N | 1 |
| Cen, Y; Chen, ZB; He, M; Wa, QB; Yu, YB; Zhou, JW | 1 |
2 other study(ies) available for quinazolines and Degenerative Disc Disease
| Article | Year |
|---|---|
Upregulation of SIRT1 by Evodiamine activates PI3K/AKT pathway and blocks intervertebral disc degeneration.
Topics: Apoptosis; Cells, Cultured; Humans; Interleukin-6; Intervertebral Disc; Intervertebral Disc Degeneration; Lipopolysaccharides; Nucleus Pulposus; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Sirtuin 1; Tumor Necrosis Factor-alpha; Up-Regulation | 2022 |
The role of quinazoline in ameliorating intervertebral disc degeneration by inhibiting oxidative stress and anti-inflammation via NF-κB/MAPKs signaling pathway.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Dose-Response Relationship, Drug; Humans; Inflammation; Intervertebral Disc Degeneration; MAP Kinase Signaling System; NF-kappa B; Oxidative Stress; Protective Agents; Quinazolines; Reactive Oxygen Species; Structure-Activity Relationship | 2020 |